Cancer BiologybioRxiv
ETV5 expression positively correlates with promoter methylation and predicts response for 5-FU-based adjuvant therapy response in proximal colon cancer
The paper identifies ETV5 expression as a biomarker predicting response to 5-FU-based adjuvant therapy in proximal colon cancer patients.
DOI 10.3389/fphar.2020.620811